ATE357927T1 - Verwendung des epidermalen wachstumsfaktors zur steigerung der gewichtszunahme beim tier - Google Patents

Verwendung des epidermalen wachstumsfaktors zur steigerung der gewichtszunahme beim tier

Info

Publication number
ATE357927T1
ATE357927T1 AT04019831T AT04019831T ATE357927T1 AT E357927 T1 ATE357927 T1 AT E357927T1 AT 04019831 T AT04019831 T AT 04019831T AT 04019831 T AT04019831 T AT 04019831T AT E357927 T1 ATE357927 T1 AT E357927T1
Authority
AT
Austria
Prior art keywords
animal
growth factor
weight gain
epidermal growth
egf
Prior art date
Application number
AT04019831T
Other languages
English (en)
Inventor
Andre G Buret
D Grant Gall
James A Hardin
Merle E Olson
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Application granted granted Critical
Publication of ATE357927T1 publication Critical patent/ATE357927T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/168Steroids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/184Hormones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1808Epidermal growth factor [EGF] urogastrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04019831T 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors zur steigerung der gewichtszunahme beim tier ATE357927T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/438,901 US5753622A (en) 1995-05-10 1995-05-10 Use of epidermal growth factor as a gastrointestinal therapeutic agent

Publications (1)

Publication Number Publication Date
ATE357927T1 true ATE357927T1 (de) 2007-04-15

Family

ID=23742496

Family Applications (3)

Application Number Title Priority Date Filing Date
AT00123426T ATE278415T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum
AT04019831T ATE357927T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors zur steigerung der gewichtszunahme beim tier
AT96913397T ATE203912T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00123426T ATE278415T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT96913397T ATE203912T1 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Country Status (12)

Country Link
US (2) US5753622A (de)
EP (3) EP1479394B1 (de)
JP (1) JP3549541B2 (de)
AT (3) ATE278415T1 (de)
AU (1) AU704675B2 (de)
CA (2) CA2220434C (de)
DE (3) DE69614377T2 (de)
DK (3) DK0824357T3 (de)
ES (2) ES2226681T3 (de)
NZ (2) NZ307134A (de)
PT (1) PT1479394E (de)
WO (1) WO1996035445A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
US5929051A (en) * 1998-05-13 1999-07-27 Carrington Laboratories, Inc. Aloe pectins
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6313103B1 (en) 1998-05-13 2001-11-06 Carrington Laboratories, Inc. Pectic substance as a growth factor stabilizer
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
JP2004536589A (ja) * 2001-05-18 2004-12-09 カナダ国 ウシ上皮成長因子の核酸及びタンパク質配列
CA2464609A1 (en) * 2001-10-26 2003-05-01 University Technologies International, Inc. Use of egf to inhibit pathogenic infections of the urogenital tract
CA2427190A1 (en) * 2002-04-30 2003-10-30 Alberta Research Council Inc. Production of recombinant epidermal growth factor in plants
JP2005529622A (ja) 2002-06-19 2005-10-06 ヴェーイーベー・ヴェーゼットウェー 腸吸収を促進するための方法および手段
JP2008514651A (ja) * 2004-09-30 2008-05-08 ユニバーシティー・テクノロジーズ・インターナショナル・インコーポレイテッド 上皮増殖因子(egf)を含んで成る再水和組成物
US8703769B2 (en) * 2005-07-15 2014-04-22 The University Of North Carolina At Chapel Hill Use of EGFR inhibitors to prevent or treat obesity
ES2405552T3 (es) 2005-11-29 2013-05-31 Actogenix N.V. Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
WO2008090223A2 (en) 2007-01-25 2008-07-31 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
US20110275566A1 (en) * 2008-10-10 2011-11-10 Nationwide Children's Hospital Inc. Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf)
CN102696887B (zh) * 2012-06-20 2013-07-31 湖南海谷生物技术有限公司 一种具有营养保健促生长功能的饲料活性蛋粉及其生产方法
US11241480B2 (en) * 2017-01-26 2022-02-08 Washington University Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
CN113813369B (zh) * 2021-11-09 2023-09-22 浙江省农业科学院 用于预防/治疗仔猪肠道损伤的egf/mmt复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
EP0292517B1 (de) * 1986-12-11 1992-09-09 Btg International Limited Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent

Also Published As

Publication number Publication date
US6656907B1 (en) 2003-12-02
AU704675B2 (en) 1999-04-29
AU5641196A (en) 1996-11-29
DK1092437T3 (da) 2005-01-31
DE69633583T2 (de) 2006-02-23
HK1072894A1 (en) 2005-09-16
CA2220434C (en) 2005-02-22
DK1479394T3 (da) 2007-06-11
CA2492724C (en) 2010-08-03
ATE278415T1 (de) 2004-10-15
CA2220434A1 (en) 1996-11-14
ES2285320T3 (es) 2007-11-16
DE69614377D1 (de) 2001-09-13
DE69614377T2 (de) 2002-05-23
EP1092437B1 (de) 2004-10-06
EP0824357A1 (de) 1998-02-25
US5753622A (en) 1998-05-19
DE69633583D1 (de) 2004-11-11
CA2492724A1 (en) 1996-11-14
DK0824357T3 (da) 2001-10-08
WO1996035445A1 (en) 1996-11-14
EP0824357B1 (de) 2001-08-08
PT1479394E (pt) 2007-04-30
NZ501482A (en) 2004-12-24
DE69637002D1 (de) 2007-05-10
DE69637002T2 (de) 2007-08-16
ES2226681T3 (es) 2005-04-01
JP3549541B2 (ja) 2004-08-04
ATE203912T1 (de) 2001-08-15
EP1092437A1 (de) 2001-04-18
JPH11505528A (ja) 1999-05-21
NZ307134A (en) 2000-02-28
EP1479394A1 (de) 2004-11-24
EP1479394B1 (de) 2007-03-28

Similar Documents

Publication Publication Date Title
ATE357927T1 (de) Verwendung des epidermalen wachstumsfaktors zur steigerung der gewichtszunahme beim tier
GR3006124T3 (de)
DE3164696D1 (en) 1-hydroxyethyl-azole derivatives, process for their preparation and their use in the regulation of plant growth and as fungicides
ATE301937T1 (de) Verfahren zur herstellung eines produkts zur erhöhung der immunantwort bei haustieren mit verwendung einer kombination von antioxidantien
SE8703696L (sv) Antioxidationsmedelskomposition och forfarande for framstellning derav
DE58906691D1 (de) Aromatische Carbonsäurederivate und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses.
HUP9903577A2 (hu) Készítmények és eljárások beauvericin-detoxikálásra
AU1277688A (en) Sustained release compositions for parenteral administration and their use
ATE283241T1 (de) Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
DE3681144D1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.
ATE47274T1 (de) Tierstreu sowie verfahren zur herstellung derselben.
ATE24505T1 (de) Cyclohexan-1,3-dionderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
ES527416A0 (es) Metodo para construir un microorganismo derivado, productor de nisina
ATE45859T1 (de) Geschmackszusammensetzung, verwendung und herstellung davon.
IL64039A (en) 1,4-dihydro-4-oxo-pyridazine-5-carboxylic acid derivatives and their use as plant growth regulators
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ATE8049T1 (de) 1,3-dioxan-5-yl-alkyltriazole, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer.
DE3582484D1 (de) Verfahren zur herstellung von benzylierten phenolen, dibenzylphenolverbindungen und die verwendung solcher phenole als antioxidantien.
JPS5729270A (en) Preparation of nonheat-coagulable egg white
DE59002155D1 (de) Verfahren zur herstellung von alkoholfreien getraenken, enthaltend fermentativ gewonnene milchsaeure.
ATE84673T1 (de) Verfahren zur herstellung von fliessfaehigen milchsaeure-zusammensetzungen.
DE3766546D1 (de) Fluoralkylsubstituierte chinolinderivate. ihre herstellung sowie verwendung zur bekaempfung unerwuenschten pflanzenwachstums.
ATE84194T1 (de) Vitamin u und verfahren zur behandlung von tieren mit vitamin u.
JPS57132868A (en) Preparation of food for storage
ATE55909T1 (de) Mittel zur verhinderung, verminderung oder verzoegerung der eiweissfaeulnis im verdauungstrakt von mensch oder tier und verfahren zur herstellung eines solchen mittels.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1479394

Country of ref document: EP

REN Ceased due to non-payment of the annual fee